These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 1354083)
1. Characterization of the promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the female rat. Dragan YP; Xu XH; Goldsworthy TL; Campbell HA; Maronpot RR; Pitot HC Carcinogenesis; 1992 Aug; 13(8):1389-95. PubMed ID: 1354083 [TBL] [Abstract][Full Text] [Related]
2. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Pitot HC; Goldsworthy T; Campbell HA; Poland A Cancer Res; 1980 Oct; 40(10):3616-20. PubMed ID: 6108157 [TBL] [Abstract][Full Text] [Related]
3. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci. Pitot HC; Goldsworthy TL; Moran S; Kennan W; Glauert HP; Maronpot RR; Campbell HA Carcinogenesis; 1987 Oct; 8(10):1491-9. PubMed ID: 2888545 [TBL] [Abstract][Full Text] [Related]
4. Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers. Xu YH; Campbell HA; Sattler GL; Hendrich S; Maronpot R; Sato K; Pitot HC Cancer Res; 1990 Feb; 50(3):472-9. PubMed ID: 1967547 [TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats. Teeguarden JG; Dragan YP; Singh J; Vaughan J; Xu YH; Goldsworthy T; Pitot HC Toxicol Sci; 1999 Oct; 51(2):211-23. PubMed ID: 10543023 [TBL] [Abstract][Full Text] [Related]
6. Quantitative stereologic study of the effects of varying the time between initiation and promotion on four histochemical markers in rat liver during hepatocarcinogenesis. Xu YH; Maronpot R; Pitot HC Carcinogenesis; 1990 Feb; 11(2):267-72. PubMed ID: 1967985 [TBL] [Abstract][Full Text] [Related]
7. Quantitative stereological evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis in the rat. Hendrich S; Campbell HA; Pitot HC Carcinogenesis; 1987 Sep; 8(9):1245-50. PubMed ID: 2887301 [TBL] [Abstract][Full Text] [Related]
8. Reversible alteration in the expression of the gap junctional protein connexin 32 during tumor promotion in rat liver and its role during cell proliferation. Neveu MJ; Hully JR; Paul DL; Pitot HC Cancer Commun; 1990; 2(1):21-31. PubMed ID: 1973356 [TBL] [Abstract][Full Text] [Related]
9. Quantitative stereological studies of a 'selection' protocol of hepatocarcinogenesis following initiation in neonatal male and female rats. Dragan YP; Campbell HA; Xu XH; Pitot HC Carcinogenesis; 1997 Jan; 18(1):149-58. PubMed ID: 9054601 [TBL] [Abstract][Full Text] [Related]
11. The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital. Goldsworthy TL; Pitot HC Carcinogenesis; 1985 Sep; 6(9):1261-9. PubMed ID: 2863007 [TBL] [Abstract][Full Text] [Related]
12. Hepatocarcinogenesis in female Sprague-Dawley rats following discontinuous treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Walker NJ; Tritscher AM; Sills RC; Lucier GW; Portier CJ Toxicol Sci; 2000 Apr; 54(2):330-7. PubMed ID: 10774815 [TBL] [Abstract][Full Text] [Related]
13. The initiation-promotion-progression model of rat hepatocarcinogenesis. Dragan YP; Sargent L; Xu YD; Xu YH; Pitot HC Proc Soc Exp Biol Med; 1993 Jan; 202(1):16-24. PubMed ID: 8093813 [TBL] [Abstract][Full Text] [Related]
14. The effect of the dose of diethylnitrosamine on the initiation of altered hepatic foci in neonatal female rats. Dragan YP; Xu YH; Pitot HC Carcinogenesis; 1993 Mar; 14(3):385-91. PubMed ID: 8095861 [TBL] [Abstract][Full Text] [Related]
15. Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats. Tritscher AM; Clark GC; Sewall C; Sills RC; Maronpot R; Lucier GW Carcinogenesis; 1995 Nov; 16(11):2807-11. PubMed ID: 7586202 [TBL] [Abstract][Full Text] [Related]
16. Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains. Viluksela M; Bager Y; Tuomisto JT; Scheu G; Unkila M; Pohjanvirta R; Flodström S; Kosma VM; Mäki-Paakkanen J; Vartiainen T; Klimm C; Schramm KW; Wärngård L; Tuomisto J Cancer Res; 2000 Dec; 60(24):6911-20. PubMed ID: 11156390 [TBL] [Abstract][Full Text] [Related]
17. Promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin and 17beta-estradiol in male Sprague-Dawley rats. Wyde ME; Cambre T; Lebetkin M; Eldridge SR; Walker NJ Toxicol Sci; 2002 Aug; 68(2):295-303. PubMed ID: 12151625 [TBL] [Abstract][Full Text] [Related]
18. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis. Lucier GW; Tritscher A; Goldsworthy T; Foley J; Clark G; Goldstein J; Maronpot R Cancer Res; 1991 Mar; 51(5):1391-7. PubMed ID: 1671757 [TBL] [Abstract][Full Text] [Related]
19. Modulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital-induced promotion of hepatocarcinogenesis in rats by the type of diet and vitamin A deficiency. Flodström S; Busk L; Kronevi T; Ahlborg UG Fundam Appl Toxicol; 1991 Feb; 16(2):375-91. PubMed ID: 2055368 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of tamoxifen and toremifene on liver and kidney tumor promotion in female rats. Dragan VP; Vaughan J; Jordan VC; Pitot HC Carcinogenesis; 1995 Nov; 16(11):2733-41. PubMed ID: 7586193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]